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BACKGROUND: In human pancreatic adenocarcinoma, nuclear factor-kappa-B (NF-kB) transcription factor is constitutively activated
that contributes to the resistance of the tumour cells to induced apoptosis. In our earlier studies, we have shown that brucein D (BD)
mediated apoptosis through activation of the p38-mitogen-activated protein kinase (MAPK) signalling pathway in pancreatic cancer
cells. This study investigated the function of reactive oxygen species (ROS) in BD-mediated p38-MAPK and NF-kB signalling
pathways in PANC-1 cells.
METHODS: Glutathione and dihydroethidium assays were used to measure the antioxidant and superoxide levels, respectively. The
protein expression of p22
phox, p67
phox and p38-MAPK were examined by western blot. The NF-kB activity was evaluated by
electrophoretic mobility shift assay.
RESULTS: Treatment with BD depleted the intracellular glutathione levels in PANC-1 cells. Brucein D triggered the activation of
NADPH oxidase isoforms, p22
phox and p67
phox while enhancing the generation of superoxide. Increases in both intracellular ROS
and NADPH oxidase activity were inhibited by an antioxidant, N-acetylcysteine (NAC). Brucein D-mediated activation of p38-MAPK
was also inhibited by NAC. However, inhibition of NF-kB activity in BD-treated cells was independent of ROS. In vivo studies showed
that BD treatment effectively reduced the rate of xenograft human pancreatic tumour in nude mice with no significant toxicity.
CONCLUSION: These data suggest that BD is an apoptogenic agent for pancreatic cancer cells through activation of the redox-sensitive
p38-MAPK pathway and inhibition of NF-kB anti-apoptotic activity in pancreatic cancer cells.
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Human pancreatic adenocarcinoma is a highly aggressive malig-
nancy intrinsically resistant to radiotherapy and chemotherapy
(Wanebo and Vezeridis, 1996). It is well known that radio- and
chemotherapy are to destroy cancer cells through an induction of
cellular oxidative stress (Lau et al, 2008a). Oxidative stress is the
result of enhanced production of intracellular reactive oxygen
species (ROS) and/or impaired function of the cellular antioxidant
defence system (Buttke and Sandstrom, 1994). Reactive oxygen
species are highly reactive O2 metabolites, including superoxide
radicals (O2
K ), hydrogen peroxide (H2O2) and hydroxyl radicals
(OH
K) (Thannickal and Fanburg, 2000); they serve as key
secondary messengers in numerous signalling pathways, eliciting
a diverse array of biological responses such as transcriptional re-
gulation, differentiation, proliferation and oncogenic transforma-
tion (Curtin et al, 2002; Martindale and Holbrook, 2002; Storz,
2006). Cellular ROS are thus essential to cell survival. On the other
hand, ROS also have an important function in pro-apoptotic
pathways (Curtin et al, 2002; Matsuzawa and Ichijo, 2005). As
intracellular redox status is critical in determining the survival and
death of cells (Hampton and Orrenius, 1998), many cancer
therapeutics target to induce cellular apoptosis by disrupting the
redox balance and depleting the intracellular thiol buffer system
through extrusion or redistribution of glutathione (GSH) (Ghibelli
et al, 1995).
One of the contributing factors to the aggressiveness, unrespon-
siveness and high mortality rate of pancreatic adenocarcinoma is
the resistance of malignant pancreatic cells to apoptosis induced
by radio- and chemo-therapeutic therapy (Wanebo and Vezeridis,
1996; Liptay et al, 2003). It has been well established that the
transcription factor nuclear factor-kappa-B (NF-kB) mediates a
central signalling pathway resulting in protection from apoptotic
cell death (Karin and Lin, 2002; Kucharczak et al, 2003). There is
mounting evidence to suggest that constitutive activation of anti-
apoptotic proteins, such as NF-kB (Aggarwal, 2000), signal
transducers and activators of transcription proteins (Battle and
Frank, 2002), heat shock proteins (Beere and Green, 2001) and
phosphatidylinositide-3-kinase (Nicholson and Anderson, 2002)
all have a function in the resistance of pancreatic cancer cells to
apoptosis. Nuclear factor-kB is a downstream effector of several
growth receptors and is constitutively activated in human
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spancreatic tumour cells (Wang et al, 1999). Nuclear factor-kBi s
normally sequestered in the cytosol in its inactive form by
inhibitory IkB proteins. Inducible phosphorylation of IkBs by
IKKs targets for polyubiquitination and subsequent degradation,
leading to activation of NF-kB (Yip-Schneider et al, 2005).
The active NF-kB complex is a homo- or heterodimer composed
of proteins from the NF-kB/Rel family, including NF-kB1
(p50/105), NF-kB2 (p52/100), RelA (p65), RelB and c-Rel
(Verma et al, 1995; Baldwin, 1996). Complex assembly of c-Rel,
RelA and RelB with their inhibitors, the IkBs, in the cytoplasm
results in inactivity as the interaction masks the nuclear
localisation signal of the NF-kB family members (Sen and
Baltimore, 1986; Baeuerle and Baltimore, 1988). Several IkB
proteins have been identified, such as IkB-a,I kB-b and IkB-e
(Verma et al, 1995; Whiteside and Israel, 1997). On stimulation,
IkB is phosphorylated by IkB kinase, leading to its rapid
degradation. Consequently, NF-kB proteins are released and
translocate into the nucleus in which they transactivate target
genes (Baldwin, 1996; Gilmore et al, 1996; Ghosh and Karin, 2002;
Li and Verma, 2002).
With an objective to search for effective chemical agents for
pancreatic cancer treatment, we have shown earlier that brucein D
(BD) possesses potent antiproliferative and apoptogenic effects on
human pancreatic cancer cells (Lau et al, 2008b). Moreover, we
have recently reported that BD induces apoptosis in pancreatic
cancer cells by activating the phosphorylation of p38-mitogen-
activated protein kinase (MAPK) (Lau et al, 2009). Although the
function of ROS in the activation of p38-MAPK (Yi et al, 2004; Lee
et al, 2008; Chen et al, 2009), and the regulation of NF-kB activity
(Hayakawa et al, 2003; Fujioka et al, 2004), has been characterised
in substances-induced apoptosis in various cancer cells, the in-
volvement of ROS in BD-induced pancreatic cancer cell apoptosis
is yet to be elucidated. Given that ROS have an important function
in an array of biological responses and diverse signalling pathways,
we hypothesised that BD activates pro-apoptotic pathways through
the enhancement of ROS production and the inhibition of NF-kB
activity in pancreatic cancer cells. To test this hypothesis, we
investigated (1) the function of oxidative stress and NF-kB activity
in BD-induced apoptosis in a pancreatic cancer cell line, PANC-1;
(2) the involvement of ROS in regulating the p38-MAPK and
NF-kB signalling pathways in BD-treated PANC-1 cells; (3) the
toxicity and anti-pancreatic cancer efficacy of BD in a pancreatic
tumour xenograft animal model.
MATERIALS AND METHODS
Cell culture and BD treatment
Unless otherwise specified, the chemicals and reagents used in the
project were obtained from Sigma-Aldrich (St Louis, MO, USA).
PANC-1, a human pancreatic adenocarcinoma cell line obtained
from American Type Culture Collection (Manassas, VA, USA), was
grown in DMEM medium supplemented with 10% foetal bovine
serum (Invitrogen, Grand Island, NY, USA), 4mML -glutamine,
4.5gl
–1 glucose, 1.5gl
–1 sodium bicarbonate, 100Uml
–1 peni-
cillin and 10Uml
–1 streptomycin (Invitrogen) in a 5% CO2, 95%
air humidified atmosphere. The procedure of the treatment of
PANC-1 cells with BD was similar to that described in our earlier
study (Lau et al, 2009).
BD used in the present experiments was isolated from the fruit
of Brucea javanica L. and its identity was confirmed by comparing
its nuclear magnetic resonance and mass spectroscopy profiles
with the published data (Yang et al, 1996), whereas its purity was
calculated to be over 95% based on HPLC analysis (data not
shown). Figure 1 shows the chemical structure of BD. For anti-
oxidative experiments, an antioxidant, N-acetylcysteine (NAC;
Sigma-Aldrich) was dissolved in phosphate-buffered saline (PBS)
and incubated with the cells 1h before BD treatment.
Glutathione assay
Glutathione levels in PANC-1 cells were determined by an earlier
described method (Ip et al, 2003; Chan and Leung, 2007). Briefly,
PANC-1 cells were harvested and washed with PBS at the end of
BD treatment. Trichloroacetic acid (25%) was mixed with PANC-1
cells at a ratio of 1:2 to precipitate protein. The mixture was
subjected to centrifugation at 7000g for 4min at 41C and the clear
supernatant was obtained. The supernatant (200ml) was diluted
with 0.1 M phosphate buffer (1ml) and GSH assay was started by
adding 3mM 5-50-dithiobis[2-nitrobenzoic acid] (50ml). The
reaction was incubated at room temperature for 5min and product
measured by absorbance at 412nm using a microplate spectro-
photometer (Fluostar Optima, BMG Labtech, Durham, NC, USA).
A standard curve was generated based on known concentration of
GSH and was used to quantify the GSH content of each sample.
Total GSH content was normalised by the protein concentration of
PANC-1 cells.
In situ detection of superoxide
Dihydroethidium (DHE) staining for superoxide was carried out as
described earlier (Cheng et al, 2008). In brief, after BD treatment,
the cells were immediately fixed with 4% paraformaldehyde
(ICN, Irvine, CA, USA) for 30min. Dihydroethidium (5mM) was
dissolved in dimethyl sulphoxide and DAPI (1:1000, Jackson
ImmunoResearch Laboratories, Burlingame, CA, USA) added to
the slides and incubated at 371C for 30min. After washing with
PBS, DHE staining was visualised using a confocal microscope
(Leica DMLB, Wetzlar, Germany) equipped with a Leica DC 200
digital camera. Fluorescence intensity of DHE-stained PANC-1
cells was quantified using EZ-C1 Viewer 3.6 (Nikon, Tokyo, Japan).
Western blot analysis
The whole-cell lysate of PANC-1 cells was obtained by lysing with
CytoBluster protein extraction reagent (Novagen, Darmstadt,
Germany), and stored at  201C. The cytoplasmic and nuclear
proteins were extracted using nuclear extraction kit (Imgenex
Corporation, San Diego, CA, USA). In brief, the cells were washed
with 5ml ice-cold PBS-PMSF after BD treatment. Buffer was
aspirated and cells collected using cell scraper with 5ml ice-cold
PBS-PSMF (Tsang et al, 2004). The cell pellets were obtained by
centrifugation for 5min at 1000rpm at 41C. Then the pellets were
incubated with 1ml hypotonic buffer on ice for 5min, followed by
OH
O
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HO
OH
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Figure 1 Chemical structure of BD, a C-20 quassinoid.
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saddition of 50ml 10% detergent solution and vigorous vortexing
for 10s. After centrifugation at 14000rpm for 30s at 41C, the
supernatant containing cytoplasmic protein and pellet containing
the nuclear fraction were obtained. The nuclear pellet was
resuspended in 100ml nuclear lysis buffer and vortexed vigorously.
The suspension was then incubated at 41C for 30min on a rocking
platform, followed by centrifugation at 14000rpm for 10min at
41C and the supernatant containing nuclear protein was obtained.
The cytoplasmic and nuclear proteins were stored at  201C and
 801C, respectively. Protein lysates were then resolved by SDS–
PAGE for 1.5h at 120V and transferred electrophoretically to
PVDF membrane for 1h at 17V. Membranes were blocked with 5%
(w/v) non-fat dry milk in PBS-T (0.1% v/v Tween-20 in PBS) for
1h and subsequently incubated overnight at 41C with primary
antibodies at the following concentrations: rabbit anti-p22
phox and
p67
phox (Santa Cruz, Santa Cruz, CA, USA) [1:500], rabbit anti-
phospho-p38-MAPK (Cell Signaling, Beverly, MA, USA) [1:1000],
rabbit anti-p38-MAPK (Cell Signaling) [1:1000], rabbit anti-IkB-a
(Sigma-Aldrich) [1:500], rabbit anti-phospho-IkB-a (Cell Signaling)
[1:1000], rabbit anti-phospho-NF-kB p65 (Cell Signaling)
[1:1000] and mouse anti-b-actin (Sigma-Aldrich) [1:2500]. The
membrane was incubated with horseradish peroxidase (HRP)-
conjugated donkey anti-rabbit IgG or HRP-conjugated sheep
anti-mouse IgG (Amersham Biosciences, Buckinghamshire, UK)
for 1h at room temperature. To verify equal loading of samples,
the membranes were subsequently incubated with mono-
clonal antibody b-actin, followed by an HRP-conjugated sheep
anti-mouse IgG. The protein bands were visualised by ECL western
blotting detection reagents (Amersham Biosciences). For analysis
of p38-MAPK, the cells were pre-incubated overnight in serum-
free DMEM medium to remove any serum effects. The density of
each band was determined by Leica IM computer software
(Wetzlar, Germany).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was performed using a
commercially available Gel Shift Assay System (Promega, Madison,
WI, USA) based on our earlier study (Chan and Leung, 2007).
Briefly, the nuclear extract (5mg) or HeLa cell extract (positive
control) was incubated with
32P-labelled oligonucleotide probe
(50-AGT TGA GGG GAC TTT CCC AGG C-30) in the presence of
binding buffer [4% glycerol, 1mM MgCl2, 0.5mM EDTA, 0.5mM
dithiothreitol, 50mM NaCl, 10mM Tris–HCl, pH 7.5 and 50mgml
–1
poly(dI-dC) poly(dI-dC)] at room temperature for 20min. After
incubation, the DNA–protein complex was resolved by 4% non-
denaturing polyacrylamide gel at 220V. The gel was dried and
exposed to X-ray film overnight at  801C and the band densities
were quantified by phosphorimager analysis using Flouro-
Chem8000 (Alpha Innotech, San Leandro, CA, USA).
RNA extraction, reverse transcription and real-time PCR
Gene expression was detected by RT–PCR. The QIAGEN RNeasy
Mini Kit (QIAGEN, Valencia, CA, USA) was used to extract total
RNA from PANC-1 cells from different treatment groups as
described earlier (Leung et al, 1999; Lam and Leung, 2002). First-
strand cDNA was generated from 2mg of total RNA using oligo(dT)
primer. b-actin cDNA was amplified as an endogenous control.
Real time–PCR was performed using iQ5 Multicolor RT–PCR
Detection System (Bio-Rad, Hercules, CA, USA) and the following
steps: 951C for 2min; 951C for 30s, 631C for 45s, 951C for 1min
(40 cycles), and 721C for 10min. The results are normalised to
b-actin and expressed as relative mRNA expression level according
to the 2-CT method (Livak and Schmittgen, 2001). Melting curve
analysis was performed to confirm amplification specificity of the
PCR products. Primer sequences for amplification of the human
genes were as follows: bcl-2 forward, 50-CGA GTT CAG TGG AGG
AGA CC -30; bcl-2 reverse, 50- GCC TAA GGA AGG CAG CTA GG -30;
XIAP forward, 50- CCT TGG GAA CAA CAT GCT AAA -30; XIAP
reverse, 50- ACC AGA CAC TCC TCA AGT GAA -30; b-actin
forward, 50-TGT CCA CCT TCC AGC AGA TGT-30 and b-actin
reverse, 50-CGG ACT CGT CAT ACT CCT GCT T-30 (Invitrogen,
Hong Kong, China).
In vivo evaluation of tumour inhibition
Six-week-old male BALB/c nude mice were supplied by the
Laboratory Animal Services Centre of The Chinese University of
Hong Kong. The animals were housed under pathogen-free
conditions in specifically designed air-controlled rooms with a
12-h light/dark cycle and fed with food and sterile water ad
libitum. The care and use of the animals were in compliance with
the institutional guidelines, and the experimental procedures were
approved by the Animal Experimentation Ethics Committee of the
CUHK (Ref. 08/032/MIS).
Xenografts were formed by subcutaneous inoculation of 5 10
6
CAPAN-2 cells (kindly provided by Dr Chaoyang Chen of the
Faculty of Medicine, CUHK) in PBS. Treatment was initiated once
the tumours reached a mean diameter of 8–10mm. Mice were then
randomised into different treatment groups of four mice each.
Brucein D dissolved in 1.68% g-cylodextrin was administered at
various concentrations (0.375, 0.75 and 1.5mgkg
–1) once daily by
tail vein injection for 10 consecutive days. The selection of the drug
concentrations was based on the results of an earlier pilot study
using a range of concentrations, that is 12, 6, 3, 1.5, 0.75 and
0.375mgkg
–1 per day, which showed that the concentrations of
1.5, 0.75 and 0.375mgkg
–1 per day elicited significant beneficial
effects on the animal without causing any toxicity. Tumour volume
(TV) and body weight were monitored daily and the TV was
calculated by using the formula TV¼4/3pr
3, where r is half of the
mean tumour diameter, measured in at least two directions (Sloss
et al, 2008).
Plasma-specific enzyme level measurement
At the end of the treatment, the blood of the mice was obtained by
cardiac puncture. After centrifugation, plasma was collected and
stored at  201C. Plasma aspartate transaminase (AST) and plasma
alanin transminase (ALT) for liver damage, and plasma lactate
dehydrogenase (LDH) and plasma creatine kinase (CK) for heart
damage were analysed according to the manufacturer’s instruc-
tions (Biosystems S.A., Barcelona, Spain).
Histological examination
At the end of the treatment, the mice were euthanised by cervical
dislocation. Heart, liver and kidney were withdrawn and fixed in
ice-cold 4% PFA in PBS at 41C overnight. The fixed tissues were
processed by Shando Pathcentre Tissue Processor (Thermo
Scientific, Waltham, MA, USA). After dehydration, the tissues
were embedded in molten paraffin (Merck, Germany) at 601C and
cast at room temperature. The paraffin-embedded tissue blocks
were sectioned at 5mm using a biocut rotary microtome machine
(Reichert-Jung, Germany) onto gelatin-coated slides. The sections
were then de-waxed by xylene and subsequently rehydrated by
ethanol gradient (absolute to 70% ethanol, each for 30s). After
several washings, the sections were stained with haematoxylin for
5–8min to locate the nucleus. Colour of haematoxylin was
adjusted by rinsing with 1% acid alcohol and Scott’s tap water.
Then the sections were stained with 1% eosin for 5min to visualise
the cytoplasm. The slides were subjected to dehydration by ethanol
gradient and xylene (three times, each for 30s), and mounted
using microscopic rapid-mounting media (Merck, Germany).
Histological changes were examined under a light microscope
(DFC 490, Olympus, Japan).
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Figure 2 Effects of BD on redox balance in PANC-1 cells. (A) BD attenuates antioxidant levels in PANC-1 cells. Cells were treated with BD for
2h and GSH levels were determined. (B, D) Representative diagram showing dihydroethidium (DHE) staining of PANC-1 cells after treatment with
vehicle (a–c), 250mM NAC (d–f), 30mM BD (g–i) and 250mM NAC þ 30mM BD (j–l) for 1 or 2h. Cells were fixed in 4% PFA and then incubated with
DHE to detect the superoxide production (red). Nuclei were counterstained with DAPI (blue). Merged images are shown for each treatment (c, f, i and l).
(C, E) Effects of BD on superoxide production in PANC-1 cells. Cells were pre-incubated with 250mM NAC for 1h and then treated with 30mM BD for 1
or 2h. The intensity of DHE staining was measured. *Po0.05 vs vehicle-control group;
#Po0.05 and
###Po0.001 vs 30mM BD-treatment group.
The results were obtained from at least three independent experiments. (The colour reproduction of this figure is available on the html full text version of
the manuscript.)
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Multiple comparisons between data sets were performed using
one-way analysis of variance followed by Dunnett’s post hoc test.
Statistical analyses were conducted using a GraphPad Prism 3.02
software package (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
Effects of BD on cellular glutathione concentration and
superoxide production
After treatment with 3 and 30mM BD for 2h, the GSH levels in
PANC-1 cells decreased significantly (Figure 2A). The depletion of
GSH levels in BD-treated PANC-1 cells showed a dose-dependent
trend, and the GSH concentrations in both 3 and 30mM BD-treated
cells were significantly lower than that of the control cells. Next,
the production of superoxide in BD-treated PANC-1 cells was
measured by in situ DHE staining. PANC-1 cells treated with 30mM
BD for 1 and 2h showed enhanced DHE staining in the nucleus of
the cells (Figure 2B and D), indicating increased production of
superoxide anions. Quantification of the fluorescence intensity
revealed that 30mM BD significantly accentuated the production of
superoxide in both treatment time periods in PANC-1 cells (Figure
2C and E). Elevation of superoxide-free radical generation induced
by BD was significantly inhibited by pre-incubation of the cells
with an antioxidant, NAC (250mM). Our results indicate that BD is
able to induce ROS by depleting GSH and enhancing superoxide
generation in PANC-1 cells.
Role of NADPH oxidase in BD-treated PANC-1 cells
NADPH oxidase activity was measured in BD-treated PANC-1 cells
for different incubation periods (15min to 2h). Western blot
results indicated that treatment with 30mM BD increased protein
expression of both p22 and p67 subunits of NADPH oxidase in
PANC-1 cells (Figure 3A and B, respectively). When compared
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Figure 3 Brucein D-treated results in an increase in the expression of NADPH oxidase. Effects of BD on the protein expression of NADPH oxidase
p22
phox (A) and p67
phox (B) in PANC-1 cells in the absence and presence of 250mM NAC. Representative images and statistical analysis of band intensity
are shown in upper and lower panels, respectively. The results were obtained from at least three independent experiments. **Po0.01 vs vehicle-control
group;
###Po0.001 vs 30mM BD-treatment group. The results were obtained from at least three independent experiments.
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swith the control, the expression of p22
phox NADPH oxidase
increased significantly after treatment with 30mM BD for 1 and 2h.
However, a significant increase of p67
phox NADPH oxidase seemed
only after 2h incubation with BD. Pre-treatment of PANC-1 cells
with 250mM NAC effectively prevented BD-mediated augmentation
in the expression of p22
phox and p67
phox NADPH oxidase.
Effects of BD-induced ROS on p38-MAPK activation
To examine the function of BD-induced ROS in mediating the
activation of p38-MAPK in PANC-1 cells, the expression of p38-
MAPK protein in each of the treatment groups was analysed. A
distinct phosphorylation of p38-MAPK in PANC-1 cells was
observed after 30mM BD treatment for 1 and 2h (Figure 4). Pre-
treatment with 250mM NAC effectively abolished the phosphoryla-
tion of p38-MAPK in BD-treated cells, indicating the requirement
of ROS for activation of p38-MAPK.
Involvement of the NF-jB signalling pathway in
BD-treated PANC-1 cells
To determine the effects of BD on the NF-kB pathway, PANC-1
cells were treated with BD for 2 or 4h. The levels of phos-
phorylated IkB-a in PANC-1 cells significantly decreased with
increasing concentrations of BD (Figure 5A). Treatment with 30mM
BD significantly accentuated IkB-a protein levels (Figure 5B),
suggesting that BD suppressed the growth of PANC-1 cells by
inhibiting NF-kB activation through augmenting IkB protein
levels. In addition, phospho-NF-kB p65 protein expression was
examined in PANC-1 cell nuclear fractions. The result showed that
phospho-NF-kB p65 expression was significantly attenuated in the
nucleus after treatment with 3 and 30mM BD for 2 or 4h
(Figure 5C).
Nuclear factor-kB-regulated genes were also examined to
determine whether BD affected their expression. The mRNA
expression of anti-apoptotic and NF-kB target genes, bcl-2 and
XIAP, was significantly decreased after BD treatment (Figure 5D).
These results indicate that inhibition of NF-kB activity by
BD-treatment affects the transcription of anti-apoptotic genes,
resulting in decreased resistance to apoptosis in PANC-1 cells.
Effects of BD-induced ROS in NF-jB signalling activity
The phosphorylation of IkB-a significantly decreased after BD
treatment for 1 or 2h (Figure 6A). Similarly, NF-kB p65 activity
was significantly reduced in the nuclear portion of PANC-1 cells
when treated with BD for 1 or 2h. To evaluate the involvement of
BD-induced ROS in NF-kB activation, PANC-1 cells were pre-
treated with NAC. Interestingly, no difference was observed in the
levels of phospho-IkB-a and phospho-NF-kB p65 between the BD
alone treated cells and that pre-treated with NAC (Figure 6A and
B). Cells pre-treated with NAC alone (without BD treatment)
exhibited no change in the activity of both phosphor-IkB-a and
phosphor-NF-kB p65 compared with the vehicle-control group.
The ability of BD to inhibit the DNA-binding activity of NF-kB
in PANC-1 cells was also examined by EMSA. As shown in
Figure 6C, constitutive NF-kB binding was evident in exponentially
growing PANC-1 cells when cultured in medium only. Treatment
with 30mM BD for 2h markedly inhibited NF-kB DNA-binding
activity in PANC-1 cells. Electrophoretic mobility shift assay
results confirmed that pre-treatment of cells with NAC did not
affect the DNA-binding activity in cells treated with either vehicle
or BD.
BD inhibits the growth of CAPAN-2 human pancreatic
tumour xenografts in vivo
Pancreatic tumours were successfully established in nude mice
after transplanting human pancreatic adenocarcinoma CAPAN-2
cells. In Figure 7A, the size of the xenograft tumours formed in
the control-treatment mice were markedly larger than that of the
1.5mgkg
–1 per day BD-treated mice. Daily TV measurements
revealed that the tumour sizes in BD-treated mice were, in general,
smaller than those of the vehicle-control group. These data indi-
cate that BD is able to significantly suppress the tumour growth
in a xenograft model in a dose-dependent manner. It should be
noted that the tumours grew exponentially in the vehicle-control
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smice. When exposed to BD at the concentrations of 0.75 and
1.5mgkg
–1 body weight, the rate of tumour growth in the
xenograft mice remained at a very low level throughout the entire
treatment period. It is worth noting that mice treated with BD
started to show significant inhibition of tumour growth on day 4
(Figure 7B).
In vivo toxicity test of BD
Mice treated with BD intravenously at dose as high as 1.5mgkg
–1
for 10 days did not show any drug-related side effects. The body
weight of mice with BD injection for 10 consecutive days did not
show significant differences to that of the g-cylodextrin-control
group (Figure 7C). Plasma was collected at the end of the
experiment and the presence of heart and liver-specific enzymes in
plasma because of organ damage was assessed. No significant
difference was found between g-cylodextrin and BD-treatment
groups regarding the activities of plasma enzymes CK, LDH, ALT
and AST (Supplementary Figure 1). Furthermore, histological
examination revealed no apparent alterations in the structural
organisation of the heart, liver and kidney tissues between the
BD-treated and control groups (Supplementary Figure 2), suggest-
ing that BD treatment at 1.5mgkg
–1for 10 days caused no toxicity
to the heart, liver and kidney tissues in the tumour-bearing mice.
DISCUSSION
Our earlier studies identified BD, a quassinoid found abundantly
in Chinese medicine Fructus Bruceae javanica, to exert potent
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santiproliferative activity in cultured human pancreatic adeno-
carcinoma cells through the induction of apoptosis involving
activation of p38-MAPK signalling (Lau et al, 2008b, 2009). In this
study, we attempted to further elucidate the underlying mechanism
by which BD mediates anti-proliferative action on pancreatic
cancer cells. Our data have shown that BD mediates activation
ROS-regulated p38-MAPK phosphorylation, whereas inhibiting
NF-kB anti-apoptotic activity in pancreatic cancer cells.
The intracellular redox status reflects a precise balance between
oxidative stress and the endogenous thiol-buffering system. It has
been shown that an imbalance of the intracellular redox state
towards oxidative stress triggers downstream cellular events, such
as alteration of mitochondrial function and cell signalling path-
ways leading to apoptotic cell death (Zhang et al, 2004). Our results
showed that in pancreatic cancer cells, treatment with BD caused
reduction of intracellular GSH in a does-dependent manner.
Glutathione is the most abundant bulk antioxidant, which prevents
apoptosis and maintains viability of the cells (Slater et al, 1995).
PANC-1 cells deprived of GSH on exposure to BD became more
vulnerable to oxidative stress when their ability to scavenge and
detoxify the various metabolically generated reactive oxygen inter-
mediates was impaired. In addition, BD treatment of PANC-1 cells
resulted in an increased generation of superoxide-free radicals.
Pre-treatment of PANC-1 cells with NAC, an antioxidant capable
of inhibiting apoptosis induced by ROS (Yang et al, 2007),
diminished the production of superoxide induced by BD. We
further showed that membrane NADPH oxidase activity was
present in PANC-1 cells, and was elevated with BD treatment. Non-
mitochrondrial NADPH oxidase is a multi-component complex
consisting of two membrane proteins, gp91
phox and p22
phox, and
four cytosolic factors, p47
phox, p67
phox, p40
phox and Rac (Babior
et al, 2002). The gp91
phox and p22
phox proteins comprise the
catalytic centre of the enzyme flavocytochrome b558. Activation of
the enzyme catalyses the conversion of molecular oxygen (O2)t o
superoxide-free radical (O2
K ), which generates oxidative stress
(Griendling et al, 2000). Our data showed that PANC-1 cells
expressed the key components of NADPH oxidase p22
phox and
p67
phox, and after treatment with BD, protein expression of
both p22
phox and p67
phox were up-regulated. The up-regulation of
p22
phox and p67
phox by BD was effectively abolished by pre-
treatment with NAC. These data indicate that NADPH oxidase is a
source of ROS on BD treatment.
Considerable evidence suggests that ROS have an important
function in key intracellular signal transduction pathways for a
variety of cellular process (Aslan and Ozben, 2003; Poli et al, 2004;
Chiarugi, 2005). Recently, ROS has been proposed to be involved
in tumour metastasis (Radisky et al, 2005; Storz, 2005). One of the
important downstream signals involved in tumour invasion is
activation of MAPKs, including ERK, p38 and JNK (Berra et al,
1995; Schonwasser et al, 1998). All MAPKs are activated by dual
phosphorylation of threonine and tyrosine motifs within the
activation loop. Once activated, MAPKs translocate to the nucleus
in which they phosphorylate target transcription factors. Our
earlier work unequivocally showed that treatment with BD
increased phosphorylation of p38-MAPK, and subsequently
activated the caspase cascade in PANC-1 cells leading to cellular
apoptosis (Lau et al, 2009). Given that BD is able to induce
oxidative stress and activate NADPH oxidase, the effect of NAC on
p38-MAPK activation in PANC-1 cells was assessed. Immuno-
blotting analyses showed that pre-treatment of NAC markedly
abrogated p38-MAPK activation in BD-treated cells, suggesting
that ROS was upstream of p38-MAPK activation.
Nuclear factor-kB has been reported to be activated in various
tumours, such as human leukaemia and lymphoma, the lung,
breast, colon and pancreatic carcinomas (Rayet and Gelinas, 1999;
Karin and Lin, 2002; Wu and Kral, 2005; Braeuer et al, 2006). The
p65 subunit of NF-kB is constitutively activated in most human
pancreatic cancer tissues and cell lines (Wang et al, 1999), and this
activation has been shown to have important functions in
tumourigenesis and liver metastasis of pancreatic adenocarcinoma
(Fujioka et al, 2003). Therefore, inhibition of NF-kB has become a
major strategy in anti-cancer therapy for pancreatic tumours.
According to our data, BD treatment inhibited phosphorylation
and degradation of the inhibitory subunit, IkB-a, thereby
sequestering NF-kB and preventing nuclear translocation and
DNA binding. The important function of NF-kB in protecting cells
against diverse apoptotic stimuli including chemo- and radio-
therapy is well known. Anti-apoptotic NF-kB-regulated genes
include genes that encode bcl-2-like proteins and IAP proteins
(IAP-1, IAP-2, XIAP) (Barkett and Gilmore, 1999). Increased
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Figure 7 In vivo analysis of the anti-tumour effects of BD. CAPAN-2 cells
were xenografted by subcutaneous inoculation into nude mice. (A) Mice
were treated with BD daily at the indicated concentrations through i.v.
administration for 10 consecutive days. The tumour volume (TV) of each
mouse was determined using the formula: TV¼4/3pr
3; n¼4, where
þPo0.05 and
þþPo0.01 comparing 0.375mgkg
–1 per day vs vehicle
control; **Po0.01 and ***Po0.001 comparing 0.75mgkg
–1 per day vs
vehicle control;
##Po0.01 and
###Po0.001 comparing 1.5mgkg
–1 per
day vs vehicle control. (B) Effects of BD on tumour xenograft growth in
nude mice after 4 days of treatment at the indicated concentrations. The
percentage of tumour growth was calculated after 4 days BD treatment;
n¼4, **Po0.01 and ***Po0.001 vs vehicle control. (C) The body weight
of each mouse was measured for 10 days.
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sactivation of p65 in PANC-1 cells was abolished by BD treatment,
leading to a decrease in the transcription of bcl-2 and XIAP.
It has been proposed that ROS are involved in the activation of
NF-kB. Certain types of compounds with antioxidant properties
block NF-kB activation and most agents that activate NF-kB are
known to trigger ROS formation. For instance, NF-kB activation
can be induced by treatment with H2O2 in certain cell lines.
However, the contribution of redox regulation in NF-kB activation
is a topic for intense debate (Brennan and O’Neill, 1995; Korn et al,
2001). In addition, several research groups have reported that
H2O2-induced NF-kB activation is highly cell type dependent
(Anderson et al, 1994; Bowie et al, 1997; Li and Karin, 1999). Thus,
we initially hypothesised that ROS induced by BD treatment serve
as secondary messengers mediating NF-kB activity. Surprisingly,
pre-treatment of the most widely used antioxidant, NAC, did
not show any regulatory effect on NF-kB in PANC-1 cells with
or without BD treatment. Hayakawa et al (2003) showed that
endogenous ROS produced through Rac/NADPH oxidase do not
mediate NF-kB signalling. It is thus plausible that the inhibition of
NF-kB activity was independent of the ROS induced by BD
treatment.
In drug development, it is essential to evaluate the toxicity and
potency of drug candidates in vivo. In our current project, we
evaluated the anti-tumour efficacy of BD in a nude mice model
xenografted with CAPAN-2 human pancreatic cancer cells. We
found that BD was able to inhibit the tumour growth without
causing mortality, significant weight loss or other noticeable side
effects on the heart, liver and kidney tissues (Supplementary
Figures 1 and 2). These observations are in agreement with our
in vitro studies showing that treatment of pancreatic cancer cells
with BD resulted in a concentration-dependent induction of
apoptosis. The potent anti-tumour activity of BD together with the
absence of toxicity renders this plant-derived quassinoid a
promising drug candidate in pancreatic cancer chemotherapy. It
seems that further in-depth pre-clinical animal studies and,
ultimately, clinical trials on BD is warranted for development of
this chemical into anti-cancer pharmaceutical.
In conclusion, this study is the first report to delineate the
mechanistic pathways associated with BD-mediated apoptosis in
pancreatic cancer cells. Brucein D depleted the intracellular GSH
levels, favouring the onset of apoptosis by passively allowing
oxidative stress to build up. Oxidative stress generated by NADPH
oxidase activation leads to p38-MAPK activation, causing apop-
tosis in pancreatic cancer cells. In addition, BD treatment inhibits
anti-apoptotic gene expression by blocking NF-kB activation,
which may increase cell susceptibility to cytotoxic agents. Taking
together the in vitro and the preliminary, but promising, in vivo
data, we believe that BD has good potential for further
development into a clinical treatment for pancreatic cancer.
ACKNOWLEDGEMENTS
This work was supported by a Direct Grant from The Chinese
University of Hong Kong (Project 2030326, awarded to ZXL and
PSL), by a General Research Fund from the Research Grants
Council of Hong Kong (Project CUHK470709) and by the Focused
Investment Scheme (The Chinese University of Hong Kong,
awarded to PSL).
Conflict of interest
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on British
Journal of Cancer website (http://www.nature.com/bjc)
REFERENCES
Aggarwal BB (2000) Apoptosis and nuclear factor-kappa B: a tale of
association and dissociation. Biochem Pharmacol 60: 1033–1039
Anderson MT, Staal FJ, Gitler C, Herzenberg LA, Herzenberg LA (1994)
Separation of oxidant-initiated and redox-regulated steps in the
NF-kappa B signal transduction pathway. Proc Natl Acad Sci USA 91:
11527–11531
Aslan M, Ozben T (2003) Oxidants in receptor tyrosine kinase signal
transduction pathways. Antioxid Redox Signal 5: 781–788
Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH
oxidase. Arch Biochem Biophys 397: 342–344
Baeuerle PA, Baltimore D (1988) I kappa B: a specific inhibitor of the
NF-kappa B transcription factor. Science 242: 540–546
Baldwin Jr AS (1996) The NF-kappa B and I kappa B proteins: new
discoveries and insights. Ann Rev Immunol 14: 649–683
Barkett M, Gilmore TD (1999) Control of apoptosis by Rel/NF-kappaB
transcription factors. Oncogene 18: 6910–6924
Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med
2: 381–392
Beere HM, Green DR (2001) Stress management – heat shock protein-70
and the regulation of apoptosis. Trends Cell Biol 11: 6–10
Berra E, Az-Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, Sanz L,
Moscat J (1995) Evidence for a role of MEK and MAPK during signal
transduction by protein kinase C zeta. EMBO J 14: 6157–6163
Bowie AG, Moynagh PN, O’Neill LA (1997) Lipid peroxidation is involved
in the activation of NF-kappaB by tumor necrosis factor but not
interleukin-1 in the human endothelial cell line ECV304. Lack of
involvement of H2O2 in NF-kappaB activation by either cytokine in
both primary and transformed endothelial cells. J Biol Chem 272:
25941–25950
Braeuer SJ, Buneker C, Mohr A, Zwacka RM (2006) Constitutively activated
nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL
resistance by up-regulation of X-linked inhibitor of apoptosis protein in
human cancer cells. Mol Cancer Res 4: 715–728
Brennan P, O’Neill LA (1995) Effects of oxidants and antioxidants on
nuclear factor kappa B activation in three different cell lines: evidence
against a universal hypothesis involving oxygen radicals. Biochim
Biophys Acta 1260: 167–175
Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of
apoptosis. Immunol Today 15: 7–10
Chan YC, Leung PS (2007) Angiotensin II type 1 receptor-dependent
nuclear factor-kappaB activation-mediated proinflammatory actions in a
rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther 323:
10–18
Chen KC, Kao PH, Lin SR, Chang LS (2009) Upregulation of Fas and FasL in
Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH
cells through ROS- and Ca2+-mediated p38 MAPK activation. J Cell
Biochem 106: 93–102
Cheng Q, Law PK, de GM, Leung PS (2008) Combination of the dipeptidyl
peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)am-
mo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor
antagonist valsartan [N-(1-oxopentyl)-N-[[20-(1H-tetrazol-5-yl)-[1,10-bi-
phenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology
and function in a mouse model of type 2 diabetes. J Pharmacol Exp Ther
327: 683–691
Chiarugi P (2005) PTPs versus PTKs: the redox side of the coin. Free Radic
Res 39: 353–364
Curtin JF, Donovan M, Cotter TG (2002) Regulation and measurement of
oxidative stress in apoptosis. J Immunol Methods 265: 49–72
Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B, Yao A, Niu J,
Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ (2004)
Stabilization of p53 is a novel mechanism for proapoptotic function of
NF-kappaB. J Biol Chem 279: 27549–27559
Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG,
Abbruzzese JL, Evans DB, Baker C, Chiao PJ (2003) Function of
nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res 9:
346–354
Role of ROS in p38-MAPK and NF-jB signalling pathways
ST Lau et al
592
British Journal of Cancer (2010) 102(3), 583–593 & 2010 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sGhibelli L, Coppola S, Rotilio G, Lafavia E, Maresca V, Ciriolo MR (1995)
Non-oxidative loss of glutathione in apoptosis via GSH extrusion.
Biochem Biophys Res Commun 216: 313–320
Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle.
Cell 109(Suppl): S81–S96
Gilmore TD, Koedood M, Piffat KA, White DW (1996) Rel/NF-kappaB/
IkappaB proteins and cancer. Oncogene 13: 1367–1378
Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in
cardiovascular biology and disease. Circ Res 86: 494–501
Hampton MB, Orrenius S (1998) Redox regulation of apoptotic cell death.
Biofactors 8: 1–5
Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H,
Karin M, Kikugawa K (2003) Evidence that reactive oxygen species do
not mediate NF-kappaB activation. EMBO J 22: 3356–3366
Ip SP, Wong TP, Tsai SJ, Leung PS (2003) The recovery of some
components of the renin angiotensin system in the rat pancreas after
chronic exposure to hypoxic condition. J Mol Endocrinol 31: 563–571
Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death.
Nat Immunol 3: 221–227
Korn SH, Wouters EF, Vos N, Janssen-Heininger YM (2001) Cytokine-
induced activation of nuclear factor-kappa B is inhibited by hydrogen
peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem
276: 35693–35700
Kucharczak J, Simmons MJ, Fan Y, Gelinas C (2003) To be, or not to be:
NF-kappaB is the answer – role of Rel/NF-kappaB in the regulation of
apoptosis. Oncogene 22: 8961–8982
Lam SY, Leung PS (2002) A locally generated angiotensin system in rat
carotid body. Regul Pept 107: 97–103
Lau AT, Wang Y, Chiu JF (2008a) Reactive oxygen species: current
knowledge and applications in cancer research and therapeutic. J Cell
Biochem 104: 657–667
Lau ST, Lin ZX, Liao Y, Zhao M, Cheng CH, Leung PS (2009) Brucein D
induces apoptosis in pancreatic adenocarcinoma cell line PANC-1
through the activation of p38-mitogen activated protein kinase.
Cancer Lett 281: 42–52
Lau ST, Lin ZX, Zhao M, Leung PS (2008b) Brucea javanica fruit induces
cytotoxicity and apoptosis in pancreatic adenocarcinoma cell lines.
Phytotherapy Res 22: 477–486
Lee KB, Kim KR, Huh TL, Lee YM (2008) Proton induces apoptosis of
hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling
pathways. Int J Oncol 33: 1247–1256
Leung PS, Wong RP, Sernia C (1999) Angiotensinogen expression by rat
epididymis: evidence for an intrinsic, angiotensin-generating enzyme.
Mol Cell Endocrinol 155: 115–122
Li N, Karin M (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J
13: 1137–1143
Li Q, Verma IM (2002) NF-kappaB regulation in the immune system.
Nat Rev Immunol 2: 725–734
Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM (2003)
Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity
in pancreatic cancer. Int J Cancer 105: 735–746
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2( Delta Delta C(T)) method.
Methods 25: 402–408
Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress:
signaling for suicide and survival. J Cell Physiol 192: 1–15
Matsuzawa A, Ichijo H (2005) Stress-responsive protein kinases in redox-
regulated apoptosis signaling. Antioxid Redox Signal 7: 472–481
Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling
pathway in human malignancy. Cell Signal 14: 381–395
Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell
signalling. Curr Med Chem 11: 1163–1182
Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D,
Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ (2005) Rac1b
and reactive oxygen species mediate MMP-3-induced EMT and genomic
instability. Nature 436: 123–127
Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human
cancer. Oncogene 18: 6938–6947
Schonwasser DC, Marais RM, Marshall CJ, Parker PJ (1998) Activation of
the mitogen-activated protein kinase/extracellular signal-regulated
kinase pathway by conventional, novel, and atypical protein kinase C
isotypes. Mol Cell Biol 18: 790–798
Sen R, Baltimore D (1986) Inducibility of kappa immunoglobulin enhancer-
binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:
921–928
Slater AF, Nobel CS, Maellaro E, Bustamante J, Kimland M, Orrenius S
(1995) Nitrone spin traps and a nitroxide antioxidant inhibit a common
pathway of thymocyte apoptosis. Biochem J 306(Pt 3): 771–778
Sloss CM, Wang F, Liu R, Xia L, Houston M, Ljungman D, Palladino MA,
Cusack Jr JC (2008) Proteasome inhibition activates epidermal growth
factor receptor (EGFR) and EGFR-independent mitogenic kinase
signaling pathways in pancreatic cancer cells. Clin Cancer Res 14:
5116–5123
Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci
10: 1881–1896
Storz P (2006) Reactive oxygen species-mediated mitochondria-to-nucleus
signaling: a key to aging and radical-caused diseases. Sci STKE 2006: re3
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling.
Am J Physiol Lung Cell Mol Physiol 279: L1005–L1028
Tsang SW, Cheng CHK, Leung PS (2004) The role of the pancreatic renin-
angiotensin system in acinar cell digestive secretion and in acute
pancreatitis. Regul Pept 119: 213–219
Verma IM, Stevenson JK, Schwarz EM, Van AD, Miyamoto S (1995)
Rel/NF-kappa B/I kappa B family: intimate tales of association and
dissociation. Genes Dev 9: 2723–2735
Wanebo HJ, Vezeridis MP (1996) Pancreatic carcinoma in perspective.
A continuing challenge. Cancer 78: 580–591
Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ (1999)
The nuclear factor-kappa B RelA transcription factor is constitutively
activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5:
119–127
Whiteside ST, Israel A (1997) I kappa B proteins: structure, function and
regulation. Semin Cancer Biol 8: 75–82
Wu JT, Kral JG (2005) The NF-kappaB/IkappaB signaling system: a
molecular target in breast cancer therapy. J Surg Res 123: 158–169
Yang J, Su Y, Richmond A (2007) Antioxidants tiron and N-acetyl-L-
cysteine differentially mediate apoptosis in melanoma cells via a reactive
oxygen species-independent NF-kappaB pathway. Free Radic Biol Med
42: 1369–1380
Yang ZQ, Xie HY, Wang JY, Sun TM, Li X (1996) Chemical studies of the
active antitumor components from the fruits of Brucea javanica
(L. Merr.). Nat Prod Res Dev 8: 35–39
Yi J, Yang J, He R, Gao F, Sang H, Tang X, Ye RD (2004) Emodin
enhances arsenic trioxide-induced apoptosis via generation of
reactive oxygen species and inhibition of survival signaling. Cancer Res
64: 108–116
Yip-Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA,
Schmidt CM (2005) Parthenolide and sulindac cooperate to mediate
growth suppression and inhibit the nuclear factor-kappa B pathway in
pancreatic carcinoma cells. Mol Cancer Ther 4: 587–594
Zhang S, Lin ZN, Yang CF, Shi X, Ong CN, Shen HM (2004) Suppressed
NF-kappaB and sustained JNK activation contribute to the sensitization
effect of parthenolide to TNF-alpha-induced apoptosis in human cancer
cells. Carcinogenesis 25: 2191–2199
Role of ROS in p38-MAPK and NF-jB signalling pathways
ST Lau et al
593
British Journal of Cancer (2010) 102(3), 583–593 & 2010 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
s